Background Placement of an interatrial shunt device reduces pulmonary capillary wedge
pressure during exercise in patients with heart failure and preserved or mildly reduced ejection …

Objectives : This study sought to determine whether the likelihood of receiving primary
intensive care unit (ICU) care by a cardiologist versus a noncardiologist was greater for …

Obesity and heart failure are two of the leading causes of morbidity and mortality in the world.
The relationship between obesity and cardiovascular diseases is complex and not fully …

Background The proportion of racial/ethnic minorities receiving ventricular assist devices (VADs)
has previously been less than expected. It is unclear if trends have changed since the …

Objectives The objective of this study was to review the characteristics of patients in cardiogenic
shock treated with TandemHeart ® percutaneous ventricular assist device (pVAD) to …

… Author links open overlay panel Sula Mazimba MD, MPH a , Timothy S. Welch MD a ,
Hunter Mwansa MD b , Khadijah K. Breathett MD c , Jamie LW Kennedy MD a , Andrew D. …

Background Acute pulmonary embolism remains a significant cause of mortality and
morbidity worldwide. Benefit of recently developed multidisciplinary PE response teams (PERT) …

Background Assessment of diffuse right ventricular (RV) fibrosis is of particular interest in
pulmonary hypertension (PH) and heart failure (HF). Current cardiovascular magnetic …

Pulmonary arterial hypertension (PAH) is a disease of the lung blood vessels that results in
right heart failure. PAH is thought to occur in about 5% to 10% of patients with hepatosplenic …

Purpose of Review This review highlights variability in prescribing of nonpharmacologic heart
failure with reduced ejection fraction (HFrEF) therapies by race, ethnicity, and gender. The …